Ann: Annual Report to shareholders, page-4

The much touted Revenue is up $600k in FY 18 to $6.462m, which presumably would be something to gladden the investor heart

But, again, all of this improved revenue, including the sale of the capital labs business came from other IQ group companies.

While the spin has always been that IQ3 is "the worlds first corporate finance and advisory firm committed to supporting Life Sciences companies", it appears they are only supporting themselves.

Is this organisation ever going to front up to the fact they have never had a paying customer that is not a related party?